Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TABP dominates the Taiwanese market for food/feed diagnostic kits (>90% share), with over sixty commercialized products. Its stem cell product for blood cancer transplantation has passed all preclinical safety and efficacy tests and will enter clinical trials soon. The company also provides drug abuse examination services, gene testing, protein drugs, and regenerative medicine solutions under strict regulatory standards.[1][2][4][5]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Taiwan Advance Bio-Pharmaceutical Inc..